论文部分内容阅读
目的调查分析354例精神科住院患者共患糖尿病的降糖药物使用情况及合理性。方法利用本院HIS系统查阅2009年11月1日至2010年10月31日精神科住院患者降糖药物用药情况,以WHO规定的药物利用指数(DUI)为评价指标,分析我院精神科住院患者降糖药物应用的合理性。结果吡格列酮、阿卡波糖、格列苯脲DUI均<1,消渴丸DUI=1,格列喹酮、二甲双胍、胰岛素DUI略大于1,联合用药符合病情。结论本院精神科患者降糖药物使用较为合理,但需提高胰岛素的临床合理应用。
Objective To investigate and analyze the usage and rationality of hypoglycemic drugs in 354 psychiatric inpatients with comorbid diabetes. Methods The HIS system of our hospital was used to refer to the medication of hypoglycemic agents in psychiatric inpatients from November 1, 2009 to October 31, 2010. The psychiatric inpatient of our hospital was analyzed with the index of drug utilization (DUI) prescribed by the WHO as evaluation index Patients hypoglycemic drug rationality. Results Pioglitazone, acarbose, glibenclamide DUI were <1, Diabetes pill DUI = 1, gliquidone, metformin, insulin DUI slightly greater than 1, the combination of medication in line with the disease. Conclusion Psychiatric patients in our hospital hypoglycemic drugs more reasonable, but the need to improve the clinical application of insulin.